<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-75517</identifier>
<setSpec>0212-6982</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">A colon adenocarcinoma and a pharyngeal carcinoma incidentally detected by means of 18F-FDG PET in a patient diagnosed of lung cancer</dc:title>
<dc:description xml:lang="en">It is not uncommon to find two or more tumors in the same patient, usually based on similar etiologic factors or the use of radiotherapy and/or chemotherapy. This occurs quite often in the case of lung cancer. In this sense, the positron emission tomography with 18F-FDG (FDG-PET) is widely used for the diagnosis and treatment of cancer patients. It is also especially useful in patients with solitary pulmonary nodule, bronchogenic carcinoma, head and neck cancer, colon cancer, tumors of unknown origin, lymphomas, etc. Its capacity to detect previously unsuspected second or third primary tumors has also been demonstrated.We report a clinical case showing how two synchronous cancers were incidentally detected in a 73-year old patient diagnosed with lung cancer and referred for (FDG-PET) study(AU)</dc:description>
<dc:creator>Caballero Gullón, L</dc:creator>
<dc:creator>Borrego Dorado, I</dc:creator>
<dc:creator>Vázquez Albertino, R</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No es infrecuente el hallazgo de dos o más tumores en un mismo paciente, usualmente sobre la base de factores etiológicos comunes o del empleo de radioterapia y/o quimioterapia. Este hecho acontece con cierta frecuencia en el caso del cáncer de pulmón. En este sentido, la tomografía por emisión de positrones con 18F-FDG (PET-FDG) es un método ampliamente utilizado en el manejo diagnóstico y terapéutico de pacientes oncológicos, y con especial utilidad en pacientes con nódulo pulmonar solitario, carcinoma broncogénico, cáncer de cabeza y cuello, cáncer colorrectal, tumor de origen desconocido, linfomas, etc. Asimismo, ha demostrado su capacidad para detectar segundos o terceros tumores primarios no sospechados previamente.Presentamos un caso clínico que muestra cómo se detectaron, de manera incidental, dos cánceres sincrónicos en un paciente de 73 años diagnosticado de cáncer de pulmón y remitido para estudio PET-FDG(AU)</dc:description>
<dc:source>Rev Esp Med Nucl;29(1): 29-31, ene.-feb. 2010. ilus</dc:source>
<dc:identifier>ibc-75517</dc:identifier>
<dc:title xml:lang="es">Adenocarcinoma de colon y carcinoma faríngeo detectados incidentalmente mediante 18F-FDG PET en paciente diagnosticado de cáncer de pulmón</dc:title>
<dc:subject>^d238^s22012</dc:subject>
<dc:subject>^d23481</dc:subject>
<dc:subject>^d10803^s22053</dc:subject>
<dc:subject>^d238^s22016</dc:subject>
<dc:subject>^d8352^s29166</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d24335^s22012</dc:subject>
<dc:subject>^d3138^s29166</dc:subject>
<dc:subject>^d8352^s22016</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d8352^s22012</dc:subject>
<dc:subject>^d3138^s22053</dc:subject>
<dc:subject>^d38793^s22039</dc:subject>
<dc:subject>^d24335^s22016</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d33478</dc:subject>
<dc:subject>^d38793^s22074</dc:subject>
<dc:subject>^d10803^s29166</dc:subject>
<dc:subject>^d33478^s22000</dc:subject>
<dc:subject>^d38793^s22066</dc:subject>
<dc:subject>^d38793^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>201002</dc:date>
</metadata>
</record>
</ibecs-document>
